Brant Point Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Brant Point Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-188,735	Closed	-$1.91M	–	123
2018 Q3	$1.91M	Hold	188,735	–	–	0.18%	108
2018 Q2	$1.89M	Sell	188,735 -215,400	-53%	-$2.16M	0.15%	104
2018 Q1	$4.04M	Buy	404,135 +103,435	+34%	+$1.03M	0.29%	60
2017 Q4	$2.98M	Buy	300,700 +202,100	+205%	+$2.01M	0.3%	85
2017 Q3	$986K	Buy	+98,600	New	+$979K	0.1%	130

Brant Point Investment Management's ORGO Position: Q4 2018 in Review

Brant Point Investment Management sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 188,735 shares — an estimated $1.91M sold.

Brant Point Investment Management first reported a position in ORGO in Q3 2017 and held it in 5 quarters. The position peaked at $4.04M in Q1 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Brant Point Investment Management reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Brant Point Investment Management sold 188,735 Organogenesis Holdings shares in Q4 2018, an estimated $1.91M.
Brant Point Investment Management first reported a position in Organogenesis Holdings in Q3 2017 and held it in 5 quarters.
Brant Point Investment Management's Organogenesis Holdings position peaked at $4.04M in Q1 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Brant Point Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.